|
⚲
|
| Keyboard |
| Ramsay David A
✚
|
|
|---|---|
| CIK # | 0001283292 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001283292] | |
| 4 | [0001283292] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Ramsay David A | |
| Halozyme Therapeutics Inc | |
| Savara Inc | |
| La Jolla Pharmaceutical Co |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Savara Inc SVRA
Common Stock
|
2025-12-19 | Sell | 20,000 | $6.06 | 121,200 |
|
Savara Inc SVRA
Common Stock
|
2025-12-09 | Grant | 40,000 | $0.00 | |
|
Savara Inc SVRA
Common Stock
|
2025-03-31 | Buy | 150,000 | $2.78 | 417,000 |
|
Savara Inc SVRA
Common Stock
|
2024-12-12 | Grant | 40,000 | $0.00 | |
|
Savara Inc SVRA
Common Stock
|
2024-11-18 | Buy | 100,000 | $2.88 | 288,000 |
|
Savara Inc SVRA
Common Stock
|
2023-12-14 | Grant | 22,500 | $0.00 | |
|
Savara Inc SVRA
Common Stock
|
2023-05-26 | Buy | 37,124 | $2.63 | 97,636 |
|
Savara Inc SVRA
Common Stock
|
2023-05-25 | Buy | 12,876 | $2.57 | 33,091 |
|
Savara Inc SVRA
Common Stock
|
2023-05-24 | Buy | 50,000 | $2.56 | 128,000 |
|
Savara Inc SVRA
Common Stock
|
2022-12-30 | Buy | 29,000 | $1.55 | 44,950 |
|
Savara Inc SVRA
Common Stock
|
2022-12-29 | Buy | 7,000 | $1.54 | 10,780 |
|
Savara Inc SVRA
Common Stock
|
2022-12-28 | Buy | 3,293 | $1.50 | 4,940 |
|
Savara Inc SVRA
Common Stock
|
2022-12-23 | Buy | 15,707 | $1.44 | 22,618 |
|
Savara Inc SVRA
Common Stock
|
2022-12-22 | Buy | 41,414 | $1.48 | 61,293 |
|
Savara Inc SVRA
Common Stock
|
2022-12-20 | Buy | 13,830 | $1.50 | 20,745 |
|
Savara Inc SVRA
Common Stock
|
2022-12-20 | Buy | 3,586 | $1.48 | 5,307 |
|
Savara Inc SVRA
Common Stock
|
2022-12-19 | Buy | 40,719 | $1.49 | 60,671 |
|
Savara Inc SVRA
Common Stock
|
2022-12-16 | Buy | 341 | $1.50 | 512 |
|
Savara Inc SVRA
Stock Option (Right to Buy) · derivative
|
2022-12-13 | Grant | 40,000 | $0.00 | |
|
Savara Inc SVRA
Common Stock
|
2022-11-23 | Buy | 4,610 | $1.44 | 6,638 |
| showing 20 of 188 most recent transactions | |||||